1 Arndt AF V, Hauri D, Heusser R, Junker C, Kuehni C, Lorez M, et al. Schweizerischer Krebsbericht 2015 – Stand und Entwicklungen. Statistik der Schweiz. 2016 (Bundesamt für Statistik, Nationalse Institut für Krebsepidemiologie und -registrierung, Schweizer Kinderkrebsregister).
2 Eggermont AM, Chiarion-Sileni V, Grob JJ, Dummer R, Wolchok JD, Schmidt H, et al. Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy. N Engl J Med. 2016;375(19):1845–55.
3 Stratigos A, Garbe C, Lebbe C, Malvehy J, del Marmol V, Pehamberger H, et al. Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline. Eur J Cancer. 2015;51(14):1989–2007.
4 Trakatelli M, Morton C, Nagore E, Ulrich C, Del Marmol V, Peris K, et al. Update of the European guidelines for basal cell carcinoma management. Eur J Dermatol. 2014;24(3):312–29.
5 Dirschka T, Gupta G, Micali G, Stockfleth E, Basset-Seguin N, Del Marmol V, et al. Real-world approach to actinic keratosis management: practical treatment algorithm for office-based dermatology. J Dermatolog Treat. 2016:1–12.
6 Nghiem PT, Bhatia S, Lipson EJ, Kudchadkar RR, Miller NJ, Annamalai L, et al. PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma. N Engl J Med. 2016;374(26):2542–52.
7 Schadendorf D, Lebbe C, Zur Hausen A, Avril MF, Hariharan S, Bharmal M, et al. Merkel cell carcinoma: Epidemiology, prognosis, therapy and unmet medical needs. Eur J Cancer. 2017;71:53–69.
8 Dummer R, Siano M, Hunger RE, Lindenblatt N, Braun R, Michielin O, et al. The updated Swiss guidelines 2016 for the treatment and follow-up of cutaneous melanoma. Swiss medical weekly. 2016;146:w14279.
9 Grob JJ, Bonerandi JJ. The ‘ugly duckling’ sign: identification of the common characteristics of nevi in an individual as a basis for melanoma screening. Arch Dermatol. 1998;134(1):103–4.
10 Ashfaq A. Marghoob JM, Ralph P. Braun. Atlas of Dermoscopy. Taylor & Francis Group, LLC. 2012.
11 Bastian BC. The molecular pathology of melanoma: an integrated taxonomy of melanocytic neoplasia. Annu Rev Pathol. 2014;9:
239-71.
12 Dummer R, Hauschild A, Lindenblatt N, Pentheroudakis G, Keilholz U; ESMO Guidelines Committee. Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26 Suppl 5:v126-32.
13 Krantz BA, Dave N, Komatsubara KM, Marr BP, Carvajal RD. Uveal melanoma: epidemiology, etiology, and treatment of primary disease. Clin Ophthalmol. 2017;11:279–89.
14 Genomic Classification of Cutaneous Melanoma.
Cell. 2015;161(7):1681–96.
15 Eggermont AM, Chiarion-Sileni V, Grob JJ, Dummer R, Wolchok JD, Schmidt H, et al. Ipilimumab versus placebo after complete resection of stage III melanoma: Initial efficacy and safety results from the EORTC 18071 phase III trial. J Clin Oncol. 2014;32(5s):suppl: abstr. LBA9008.
16 Dummer R, Hoeller C, Gruter IP, Michielin O. Combining talimogene laherparepvec with immunotherapies in melanoma and other solid tumors. Cancer immunology, immunotherapy: CII. 2017.
17 Amann VC, Ramelyte E, Thurneysen S, Pitocco R, Bentele-Jaberg N, Goldinger SM, et al. Developments in targeted therapy in melanoma. Eur J Surg Oncol. 2017;43(3):581–93.
18 Dummer R, Ramelyte E, Levesque M, Goldinger SM, Braun RP. Critical aspects to achieve a high-quality melanoma clinic. Curr Opin Oncol. 2017;29(2):145–50.
– Dirschka T, Gupta G, Micali G, Stockfleth E, Basset-Séguin N, Del Marmol V, Dummer R, Jemec GB, Malvehy J, Peris K, Puig S, Stratigos AJ, Zalaudek I, Pellacani G, Real-world approach to actinic keratosis management: practical treatment algorithm for office-based dermatology. J Dermatolog Treat. 2016:1–12.
– NCCN Guidelines: Squamous Cell Skin Cancer, Version 1.2017 – October 3, 2016.
– Trakatelli M, Morton C, Nagore E, Ulrich C, Del Marmol V, Peris K, Basset-Seguin N; Update of the European guidelines for basal cell carcinoma management. Eur J Dermatol. 2014;24(3):312–29. doi: 10.1684/ejd.2014.2271.
– Dummer R, Siano M, Hunger R, Lindenblatt N, Braun R, Michielin O, Mihic-Probst D, von Moos R, Najafi Y, Guckenberger M, Arnold A, The updated Swiss guidelines 2016 for the treatment and follow-up of cutaneous melanoma. Swiss Med Wkly. 2016;146:w 14279. Published 22 February 2016.